Can Doctors Predict Response to Multiple Myeloma Therapy? A Team Effort to Do Just That with Dr. Brian Van Ness, PhD, University of Minnesota

Important Lessons Learned from the Measles Virus in Multiple Myeloma and the Next Step to Advance the Fascinating Viro Therapy with Dr. Frits van Rhee and Dr. Stephen Russell

The Exciting Potential of CAR T Cells for Multiple Myeloma Treatment with a Carefully Designed Strategy to Boost Results and Mitigate Safety Concerns. Dr. Hermann Einsele, MD and Dr. Michael Hudecek, MD, University of Würzburg, Germany

Your very own mouse avatar; shortening the time to a cure for YOUR multiple myeloma. Dr. Morgan, Dr. Heuck, Dr. Weinhold, Dr. Epstein and Dr. Yaccoby, UAMS

Multiple myeloma patients pick up more of the CD28 protein as they relapse. A new solution for this relapsed/refractory target and for 14;16 patients specifically with Dr. Carmen Baldino, PhD and Dr. Kelvin Lee, MD

New solutions for multiple myeloma patients with 14;16 and 14;20 translocations with Dr. Frank Zhan, MD, PhD and Dr. Guido Tricot, MD, PhD, University of Iowa

Personalized treatment for normal and high-risk patients using immunotherapy and transplant with Dr. Ivan Borrello, MD, PhD, Johns Hopkins

Which myeloma cells are surviving beyond chemotherapy? Newer, more sophisticated monitoring to pinpoint surviving cells in order to find better targets with Dr. Bruno Paiva, PhD, University of Navarra

Overcoming Deletion 17p Using a Specifically Targeted Therapy with Dr. Robert Orlowski, MD, PhD, MD Anderson